I wish to restate an important point, . . . pacing ALS patients ought to be valuable in medical research studies even if they are not freshly diagnosed. Where their diaphragm remains unaffected or the impact has begun but the impact is not extensive, researchers ought to find ALS patient candidacy for studies valuable even if the study is not directed at the ALS patient because the data obtainable from dEMG may show evidence valuable in their immediate research interest or valuable to ALS researchers if the dEMG data shows some affect on the ALS disease processes.